These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3198297)

  • 1. Pharmacokinetic study of a new sustained release preparation of propranolol in normal healthy volunteers.
    Biswas NR; Garg SK; Lal R; Kumar N; Gyawali K; Narendranath KA; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1988 Sep; 26(9):436-8. PubMed ID: 3198297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of propranolol after single and multiple dosing with sustained release propranolol or propranolol CR (innopran XL) , a new chronotherapeutic formulation.
    Sica D; Frishman WH; Manowitz N
    Heart Dis; 2003; 5(3):176-81. PubMed ID: 12783630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic evaluation of conventional and controlled release dosage form of propranolol.
    Das SK; Chattaraj SC
    Arzneimittelforschung; 1990 Jul; 40(7):752-4. PubMed ID: 2222550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic characteristics of a new multiple unit sustained release formulation of sodium valproate.
    Wangemann M; Retzow A; Vens-Cappell B
    Int J Clin Pharmacol Ther; 1999 Feb; 37(2):100-8. PubMed ID: 10082174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioequivalence of a new sustained-release formulation of sodium valproate, valproate modified-release granules, compared with existing sustained-release formulations after once- or twice-daily administration.
    Dulac O; Alvarez JC
    Pharmacotherapy; 2005 Jan; 25(1):35-41. PubMed ID: 15767218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative pharmacokinetic and pharmacodynamic study of four different brands of propranolol in normal volunteers.
    Biswas NR; Garg SK; Kumar N; Mukherjee S; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1989 Oct; 27(10):515-9. PubMed ID: 2583878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential drug interactions with misoprostol: effects on the pharmacokinetics of antipyrine and propranolol.
    Bennett PN; Fenn GC; Notarianni LJ
    Postgrad Med J; 1988; 64 Suppl 1():21-4. PubMed ID: 3138681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bioavailability of new nifedipine preparations in man. 1. Pharmacokinetics of nifedipine in the form of sustained-release tablets].
    Lutz D; Pabst G; Dahmen W; Molz KH; Jaeger H
    Arzneimittelforschung; 1985; 35(12):1840-2. PubMed ID: 4096741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propranolol pharmacokinetics and pharmacodynamics after single doses and at steady-state.
    Lalonde RL; Pieper JA; Straka RJ; Bottorff MB; Mirvis DM
    Eur J Clin Pharmacol; 1987; 33(3):315-8. PubMed ID: 3691620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steady-state pharmacokinetics of propranolol enantiomers in healthy male volunteers.
    Paradiso-Hardy FL; Walker SE; Bowles SK
    Int J Clin Pharmacol Ther; 1998 Jul; 36(7):370-5. PubMed ID: 9707351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic and pharmacodynamic studies with a new controlled-release formulation of propranolol in normal volunteers: a comparison with other commercially available formulations.
    Perucca E; Grimaldi R; Gatti G; Caravaggi M; Crema F; Lecchini S; Frigo GM
    Br J Clin Pharmacol; 1984 Jul; 18(1):37-43. PubMed ID: 6743489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic properties of a new sustained-release theophylline preparation.
    Dahlqvist R; Billing B
    Int J Clin Pharmacol Ther Toxicol; 1983 Feb; 21(2):69-72. PubMed ID: 6840927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of a sustained-release dosage form of clomipramine.
    Herrera D; Mayet L; Galindo MC; Jung H
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1488-93. PubMed ID: 11185671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of terbutaline given in slow-release tablets.
    Nyberg L; Kennedy BM
    Eur J Respir Dis Suppl; 1984; 134():119-39. PubMed ID: 6586473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacokinetics and pharmacological actions of a long-acting formulation of propranolol.
    Ohashi K; Ebihara A; Kondo K; Usami M
    Arzneimittelforschung; 1984; 34(4):507-12. PubMed ID: 6378211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steady-state pharmacokinetics of a once-daily theophylline formulation (Euphylong) when given twice daily.
    Götz J; Sauter R; Steinijans VW; Jonkman JH
    Int J Clin Pharmacol Ther; 1994 Apr; 32(4):168-73. PubMed ID: 8032575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and evaluation of a novel delayed-onset sustained-release system of propranolol hydrochloride.
    Feng XM; Ren Q; Zhang WZ; Shen HF; Rong ZX; Fang C; Chen HZ
    J Pharm Pharmacol; 2008 Jul; 60(7):817-22. PubMed ID: 18549667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and bioavailability of three different galenic nifedipine preparations.
    Pabst G; Lutz D; Molz KH; Dahmen W; Jaeger H
    Arzneimittelforschung; 1986 Feb; 36(2):256-60. PubMed ID: 3964332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacokinetics of a theophylline sustained-release formulation after single and twice daily dosage].
    Fuchs WS; von Nieciecki A; Pabst G; Müller M; Dilger C; Gay S; Laicher A; Stanislaus F
    Arzneimittelforschung; 1998 May; 48(5A):589-92. PubMed ID: 9676350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vivo verification of in vitro release specifications of a theophylline sustained-release preparation].
    von Nieciecki A; Fuchs WS; Pabst G; Müller M; Dilger C; Gay S; Laicher A; Stanislaus F
    Arzneimittelforschung; 1998 May; 48(5A):580-3. PubMed ID: 9676348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.